Global Neuroscience Antibodies and Assays Market Research Report 2023

Report ID: 1983937 | Published Date: Jan 2025 | No. of Page: 86 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Neuroscience Antibodies and Assays Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Consumables
        1.2.3 Instruments
    1.3 Market by Application
        1.3.1 Global Neuroscience Antibodies and Assays Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Pharmaceutical & Biotechnology Companies
        1.3.3 Academic & Research Institutes
        1.3.4 Hospitals & Diagnostic Centers
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Neuroscience Antibodies and Assays Market Perspective (2017-2028)
    2.2 Neuroscience Antibodies and Assays Growth Trends by Region
        2.2.1 Neuroscience Antibodies and Assays Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Neuroscience Antibodies and Assays Historic Market Size by Region (2017-2022)
        2.2.3 Neuroscience Antibodies and Assays Forecasted Market Size by Region (2023-2028)
    2.3 Neuroscience Antibodies and Assays Market Dynamics
        2.3.1 Neuroscience Antibodies and Assays Industry Trends
        2.3.2 Neuroscience Antibodies and Assays Market Drivers
        2.3.3 Neuroscience Antibodies and Assays Market Challenges
        2.3.4 Neuroscience Antibodies and Assays Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Neuroscience Antibodies and Assays Players by Revenue
        3.1.1 Global Top Neuroscience Antibodies and Assays Players by Revenue (2017-2022)
        3.1.2 Global Neuroscience Antibodies and Assays Revenue Market Share by Players (2017-2022)
    3.2 Global Neuroscience Antibodies and Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Neuroscience Antibodies and Assays Revenue
    3.4 Global Neuroscience Antibodies and Assays Market Concentration Ratio
        3.4.1 Global Neuroscience Antibodies and Assays Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Neuroscience Antibodies and Assays Revenue in 2021
    3.5 Neuroscience Antibodies and Assays Key Players Head office and Area Served
    3.6 Key Players Neuroscience Antibodies and Assays Product Solution and Service
    3.7 Date of Enter into Neuroscience Antibodies and Assays Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroscience Antibodies and Assays Breakdown Data by Type
    4.1 Global Neuroscience Antibodies and Assays Historic Market Size by Type (2017-2022)
    4.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Type (2023-2028)
5 Neuroscience Antibodies and Assays Breakdown Data by Application
    5.1 Global Neuroscience Antibodies and Assays Historic Market Size by Application (2017-2022)
    5.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Neuroscience Antibodies and Assays Market Size (2017-2028)
    6.2 North America Neuroscience Antibodies and Assays Market Size by Country (2017-2022)
    6.3 North America Neuroscience Antibodies and Assays Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Neuroscience Antibodies and Assays Market Size (2017-2028)
    7.2 Europe Neuroscience Antibodies and Assays Market Size by Country (2017-2022)
    7.3 Europe Neuroscience Antibodies and Assays Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Neuroscience Antibodies and Assays Market Size (2017-2028)
    8.2 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Country (2017-2022)
    8.3 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Neuroscience Antibodies and Assays Market Size (2017-2028)
    9.2 Latin America Neuroscience Antibodies and Assays Market Size by Country (2017-2022)
    9.3 Latin America Neuroscience Antibodies and Assays Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Neuroscience Antibodies and Assays Market Size (2017-2028)
    10.2 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2017-2022)
    10.3 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Thermo Fisher
        11.1.1 Thermo Fisher Company Detail
        11.1.2 Thermo Fisher Business Overview
        11.1.3 Thermo Fisher Neuroscience Antibodies and Assays Introduction
        11.1.4 Thermo Fisher Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
        11.1.5 Thermo Fisher Recent Development
    11.2 Abcam
        11.2.1 Abcam Company Detail
        11.2.2 Abcam Business Overview
        11.2.3 Abcam Neuroscience Antibodies and Assays Introduction
        11.2.4 Abcam Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
        11.2.5 Abcam Recent Development
    11.3 Bio-Rad
        11.3.1 Bio-Rad Company Detail
        11.3.2 Bio-Rad Business Overview
        11.3.3 Bio-Rad Neuroscience Antibodies and Assays Introduction
        11.3.4 Bio-Rad Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
        11.3.5 Bio-Rad Recent Development
    11.4 Merck
        11.4.1 Merck Company Detail
        11.4.2 Merck Business Overview
        11.4.3 Merck Neuroscience Antibodies and Assays Introduction
        11.4.4 Merck Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
        11.4.5 Merck Recent Development
    11.5 Cell Signaling Technology
        11.5.1 Cell Signaling Technology Company Detail
        11.5.2 Cell Signaling Technology Business Overview
        11.5.3 Cell Signaling Technology Neuroscience Antibodies and Assays Introduction
        11.5.4 Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
        11.5.5 Cell Signaling Technology Recent Development
    11.6 Genscript
        11.6.1 Genscript Company Detail
        11.6.2 Genscript Business Overview
        11.6.3 Genscript Neuroscience Antibodies and Assays Introduction
        11.6.4 Genscript Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
        11.6.5 Genscript Recent Development
    11.7 Rockland Immunochemicals
        11.7.1 Rockland Immunochemicals Company Detail
        11.7.2 Rockland Immunochemicals Business Overview
        11.7.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Introduction
        11.7.4 Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
        11.7.5 Rockland Immunochemicals Recent Development
    11.8 BioLegend
        11.8.1 BioLegend Company Detail
        11.8.2 BioLegend Business Overview
        11.8.3 BioLegend Neuroscience Antibodies and Assays Introduction
        11.8.4 BioLegend Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
        11.8.5 BioLegend Recent Development
    11.9 Santa Cruz Biotechnology
        11.9.1 Santa Cruz Biotechnology Company Detail
        11.9.2 Santa Cruz Biotechnology Business Overview
        11.9.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Introduction
        11.9.4 Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
        11.9.5 Santa Cruz Biotechnology Recent Development
    11.10 Roche
        11.10.1 Roche Company Detail
        11.10.2 Roche Business Overview
        11.10.3 Roche Neuroscience Antibodies and Assays Introduction
        11.10.4 Roche Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
        11.10.5 Roche Recent Development
    11.11 Siemens
        11.11.1 Siemens Company Detail
        11.11.2 Siemens Business Overview
        11.11.3 Siemens Neuroscience Antibodies and Assays Introduction
        11.11.4 Siemens Revenue in Neuroscience Antibodies and Assays Business (2017-2022)
        11.11.5 Siemens Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Neuroscience Antibodies and Assays Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Consumables
    Table 3. Key Players of Instruments
    Table 4. Global Neuroscience Antibodies and Assays Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Neuroscience Antibodies and Assays Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Neuroscience Antibodies and Assays Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Neuroscience Antibodies and Assays Market Share by Region (2017-2022)
    Table 8. Global Neuroscience Antibodies and Assays Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Neuroscience Antibodies and Assays Market Share by Region (2023-2028)
    Table 10. Neuroscience Antibodies and Assays Market Trends
    Table 11. Neuroscience Antibodies and Assays Market Drivers
    Table 12. Neuroscience Antibodies and Assays Market Challenges
    Table 13. Neuroscience Antibodies and Assays Market Restraints
    Table 14. Global Neuroscience Antibodies and Assays Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Neuroscience Antibodies and Assays Market Share by Players (2017-2022)
    Table 16. Global Top Neuroscience Antibodies and Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays as of 2021)
    Table 17. Ranking of Global Top Neuroscience Antibodies and Assays Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Neuroscience Antibodies and Assays Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Neuroscience Antibodies and Assays Product Solution and Service
    Table 21. Date of Enter into Neuroscience Antibodies and Assays Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Neuroscience Antibodies and Assays Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Neuroscience Antibodies and Assays Revenue Market Share by Type (2017-2022)
    Table 25. Global Neuroscience Antibodies and Assays Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Neuroscience Antibodies and Assays Revenue Market Share by Type (2023-2028)
    Table 27. Global Neuroscience Antibodies and Assays Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Neuroscience Antibodies and Assays Revenue Market Share by Application (2017-2022)
    Table 29. Global Neuroscience Antibodies and Assays Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Neuroscience Antibodies and Assays Revenue Market Share by Application (2023-2028)
    Table 31. North America Neuroscience Antibodies and Assays Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Neuroscience Antibodies and Assays Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Neuroscience Antibodies and Assays Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Neuroscience Antibodies and Assays Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Neuroscience Antibodies and Assays Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Neuroscience Antibodies and Assays Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Thermo Fisher Company Detail
    Table 42. Thermo Fisher Business Overview
    Table 43. Thermo Fisher Neuroscience Antibodies and Assays Product
    Table 44. Thermo Fisher Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
    Table 45. Thermo Fisher Recent Development
    Table 46. Abcam Company Detail
    Table 47. Abcam Business Overview
    Table 48. Abcam Neuroscience Antibodies and Assays Product
    Table 49. Abcam Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
    Table 50. Abcam Recent Development
    Table 51. Bio-Rad Company Detail
    Table 52. Bio-Rad Business Overview
    Table 53. Bio-Rad Neuroscience Antibodies and Assays Product
    Table 54. Bio-Rad Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
    Table 55. Bio-Rad Recent Development
    Table 56. Merck Company Detail
    Table 57. Merck Business Overview
    Table 58. Merck Neuroscience Antibodies and Assays Product
    Table 59. Merck Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
    Table 60. Merck Recent Development
    Table 61. Cell Signaling Technology Company Detail
    Table 62. Cell Signaling Technology Business Overview
    Table 63. Cell Signaling Technology Neuroscience Antibodies and Assays Product
    Table 64. Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
    Table 65. Cell Signaling Technology Recent Development
    Table 66. Genscript Company Detail
    Table 67. Genscript Business Overview
    Table 68. Genscript Neuroscience Antibodies and Assays Product
    Table 69. Genscript Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
    Table 70. Genscript Recent Development
    Table 71. Rockland Immunochemicals Company Detail
    Table 72. Rockland Immunochemicals Business Overview
    Table 73. Rockland Immunochemicals Neuroscience Antibodies and Assays Product
    Table 74. Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
    Table 75. Rockland Immunochemicals Recent Development
    Table 76. BioLegend Company Detail
    Table 77. BioLegend Business Overview
    Table 78. BioLegend Neuroscience Antibodies and Assays Product
    Table 79. BioLegend Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
    Table 80. BioLegend Recent Development
    Table 81. Santa Cruz Biotechnology Company Detail
    Table 82. Santa Cruz Biotechnology Business Overview
    Table 83. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Product
    Table 84. Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
    Table 85. Santa Cruz Biotechnology Recent Development
    Table 86. Roche Company Detail
    Table 87. Roche Business Overview
    Table 88. Roche Neuroscience Antibodies and Assays Product
    Table 89. Roche Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
    Table 90. Roche Recent Development
    Table 91. Siemens Company Detail
    Table 92. Siemens Business Overview
    Table 93. Siemens Neuroscience Antibodies and AssaysProduct
    Table 94. Siemens Revenue in Neuroscience Antibodies and Assays Business (2017-2022) & (US$ Million)
    Table 95. Siemens Recent Development
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neuroscience Antibodies and Assays Market Share by Type: 2021 VS 2028
    Figure 2. Consumables Features
    Figure 3. Instruments Features
    Figure 4. Global Neuroscience Antibodies and Assays Market Share by Application in 2021 & 2028
    Figure 5. Pharmaceutical & Biotechnology Companies Case Studies
    Figure 6. Academic & Research Institutes Case Studies
    Figure 7. Hospitals & Diagnostic Centers Case Studies
    Figure 8. Neuroscience Antibodies and Assays Report Years Considered
    Figure 9. Global Neuroscience Antibodies and Assays Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Neuroscience Antibodies and Assays Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Neuroscience Antibodies and Assays Market Share by Region: 2021 VS 2028
    Figure 12. Global Neuroscience Antibodies and Assays Market Share by Players in 2021
    Figure 13. Global Top Neuroscience Antibodies and Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Neuroscience Antibodies and Assays Revenue in 2021
    Figure 15. North America Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Neuroscience Antibodies and Assays Market Share by Country (2017-2028)
    Figure 17. United States Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Neuroscience Antibodies and Assays Market Share by Country (2017-2028)
    Figure 21. Germany Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Neuroscience Antibodies and Assays Market Share by Region (2017-2028)
    Figure 29. China Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Neuroscience Antibodies and Assays Market Share by Country (2017-2028)
    Figure 37. Mexico Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Neuroscience Antibodies and Assays Market Share by Country (2017-2028)
    Figure 41. Turkey Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Neuroscience Antibodies and Assays Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Thermo Fisher Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
    Figure 44. Abcam Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
    Figure 45. Bio-Rad Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
    Figure 46. Merck Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
    Figure 47. Cell Signaling Technology Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
    Figure 48. Genscript Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
    Figure 49. Rockland Immunochemicals Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
    Figure 50. BioLegend Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
    Figure 51. Santa Cruz Biotechnology Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
    Figure 52. Roche Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
    Figure 53. Siemens Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Thermo Fisher
Abcam
Bio-Rad
Merck
Cell Signaling Technology
Genscript
Rockland Immunochemicals
BioLegend
Santa Cruz Biotechnology
Roche
Siemens
Frequently Asked Questions
Neuroscience Antibodies and Assays report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neuroscience Antibodies and Assays report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neuroscience Antibodies and Assays report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports